Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Frontal Lobe DementiaFrontotemporal Lobe DementiaSemantic Dementia
Interventions
DRUG

memantine

memantine 10mg BID

DRUG

Placebo pill

Placebo pill BID

Trial Locations (9)

21205

Johns Hopkins Hospital, Baltimore

32224

Mayo Clinic - Jacksonville, Jacksonville

44120

University Hospitals of Cleveland / Case Medical Center, Cleveland

55905

Mayo Clinic - Rochester, Rochester

60611

Northwestern University, Chicago

90095

University of California, Los Angeles, Los Angeles

94143-1207

University California, San Francisco, San Francisco

27599-7025

University of North Carolina at Chapel Hill, Chapel Hill

19104-4283

University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

University of California, San Francisco

OTHER